Menu

Press Releases

Real-World Observational Study in the U.S. Veterans Affairs System Evaluating Use of Merck’s ZEPATIER® (Elbasvir and Grazoprevir) Shows High Sustained Virologic Response Rates in Patients with Chronic Hepatitis C

Study Evaluated VA Population with High Incidence of Co-Morbidities KENILWORTH, N.J. April 21, 2017 –(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of findings from a retrospective database analysis of patients with chronic hepatitis C virus (HCV) infection who were administered ZEPATIER® in the U.S. […]

Cancer Center First in State to Earn Rigorous Radiotherapy Certification

GREENSBORO, N.C. April 20, 2017 – Novalis Certified demonstrates Cone Health Cancer Center’s commitment to quality and safety when delivering precision radiation to treat cancer. Cone Health Cancer Center at Wesley Long Hospital is the first cancer center in North Carolina to become Novalis® Certified. The certification means the radiosurgery program at Cone Health meets […]

Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neurology (AAN) Annual Meeting

INDIANAPOLIS, April 20, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will highlight Phase 2 data evaluating galcanezumab for the prevention of migraine at the American Academy of Neurology (AAN) annual meeting, which will take place April 22-28, 2017, in Boston. Lilly will present four abstracts at AAN, including safety and patient outcomes data for […]

Duke Health and WakeMed Agree to Collaborate on Cancer Care in Wake County

Duke Health and WakeMed Agree to Collaborate on Cancer Care in Wake County DURHAM, N.C. April 20, 2017 – Duke Health and WakeMed Health & Hospitals have announced the signing of agreements to create Cancer Care Plus+, an innovative cancer care collaboration that will serve the growing cancer care needs of patients in Wake County. […]

Allergan Partners with TARGET PharmaSolutions to Advance NASH Research

, , ,

Five-Year Study to Enroll 15,000 Adults and Children with NAFLD or NASH NASH Fastest Growing Cause of Liver Cancer and Liver Transplant in the U.S. DUBLIN, April 20, 2017 /PRNewswire/ — Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on real world evidence, […]

Allergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical Dystonia and Alzheimer’s Disease at the American Academy of Neurology Meeting in Boston

, , ,

DUBLIN, April 20, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that it has 13 presentations at the upcoming 69th American Academy of Neurology (AAN) annual meeting taking place April 22-28, 2017 in Boston. Among the highlights are three podium presentations on Chronic Migraine disease awareness and post-stroke spasticity […]

Merck Donates $300,000 to Support Neglected Tropical Disease Elimination Efforts in Africa

KENILWORTH, N.J. April 20, 2017 –(BUSINESS WIRE)–Merck, known as MSD outside the United States and Canada, announced today a $300,000 cash donation to support non-governmental organization (NGO) partners working to eliminate river blindness (onchocerciasis) and lymphatic filariasis (LF) in Africa. The donation will be offered to 10 NGOs beginning this year, and will be administered […]

Can Hepatitis C Be Eliminated by 2030? On the Path to Zero

, ,

AbbVie’s broad commitment to a global effort to cure hepatitis C (HCV) led to a policy, advocacy and awareness initiative called Path to Zero: Fresh Thinking on the Road to Eliminating HCV. April 20, 2017 – The Economist Group’s Path to Zero program, sponsored by AbbVie, aims to foster a global dialogue around innovative solutions […]

Merck Underscores Continued Commitment to Fighting Infectious Diseases With More than 25 Data Presentations at ECCMID 2017

KENILWORTH, N.J. April 19, 2017 –(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that researchers are scheduled to provide more than 25 scientific data presentations on the company’s established and investigational infectious disease medicines at this year’s 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April […]

«‹ 60 61 62 63›»